Skip to main content
. Author manuscript; available in PMC: 2011 Nov 15.
Published in final edited form as: Cancer Res. 2010 Nov 2;70(22):9197–9206. doi: 10.1158/0008-5472.CAN-10-1568

Figure 2.

Figure 2

Up regulation of DLX5 in ovarian cancer. (A, B) Expression of DLX5 protein in ovarian cancer cell lines. DLX5 protein was analyzed by immunoblotting at short (A) and longer (B) exposure. Lysate from 293T cell cells transfected with a pcDNA3.1-human DLX5 plasmid (lane designated as Overexpress) was loaded as a positive control (A). (C) Expression of DLX5 in human malignant ovarian cancer specimens. DLX5 protein levels in ovarian carcinoma samples were determined by immunoblot analysis.